Shop by goal

  • Metabolic Signalling
  • GH-Axis Research
  • Muscle & IGF Research
  • Tissue and Cellular Models
  • Regenerative Research
  • Cellular Senescence Research
  • Cognitive Research
  • Multi-Compound Blends
  • Accessories
  • All compounds →
  • Popular compounds

  • BPC-157
  • TB-500
  • GHK-Cu
  • Retatrutide
  • Semaglutide
  • Ipamorelin
  • All bestsellers →
  • Research resources

  • Research Areas
  • Certificates of Analysis
  • Research Glossary
  • Compare Compounds
  • Peptide Guides
  • Delivery Guide
  • Track Order
  • Recently viewed

  • All peptide guides
  • Crypto Blog
  • How to Reconstitute
  • Reconstitution Calculator
  • How to Store
  • Research
  • Certificates of Analysis
  • Sign In
  • Create Account
  • My Account
  • My Orders
  • My Referrals
  • Log Out
  • Track Order
  • Refer a Friend
  • Follow us on Twitter/X
  • How-to guides

    LL-37: Immune / Anti-Inflammatory research guide

    In short: LL-37 human cathelicidin antimicrobial peptide (37 aa, +6 net charge) disrupts bacterial membranes via amphipathic alpha-helical channel formation and NF-κB modulation. It is studied in preclinical (cell and animal) research and is supplied strictly for laboratory use, not for human or clinical use.

    Not medical advice. LL-37 is a research compound. This guide does not provide dosing, diagnosis, therapy recommendations, or claims about effects in humans.

    LL-37 at a glance

    Compound type
    Research peptide
    Research category
    Immune / Anti-Inflammatory
    Also known as
    LL-37, Cathelicidin, hCAP-18 Active Fragment, Human Cathelicidin Antimicrobial Peptide, CAMP, Cathelicidin LL-37, Antimicrobial Peptide LL-37
    Molecular weight
    4493.33 Da
    Research-grade purity
    >99% HPLC
    Evidence context
    Preclinical / research use only
    Regulatory status
    Not an approved medicine. Supplied as a research compound
    Last reviewed
    16 June 2026

    What to know first

  • Forms amphipathic tetrameric transmembrane channels disrupting bacterial membrane integrity via electrostatic insertion
  • Broad-spectrum antimicrobial activity against Gram-positive, Gram-negative bacteria, fungi, and enveloped viruses
  • Inhibits bacterial biofilm formation through membrane disruption at sub-MIC concentrations
  • Interacts with intracellular polyanionic targets (DNA, RNA, ribosomes) for secondary bactericidal mechanisms
  • Details and limits sit in the sections below. Research use only.

    What LL-37 is

    LL-37 is the only human cathelicidin - a 37-residue amphipathic antimicrobial peptide that punches holes in bacterial membranes while simultaneously acting as an alarmin that orchestrates the innate immune response.

    One-paragraph overview from our research datasheet. Still scientific, but faster to read than the full mechanism list below.

    LL-37 human cathelicidin antimicrobial peptide (37 aa, +6 net charge) disrupts bacterial membranes via amphipathic alpha-helical channel formation and NF-κB modulation.

    Research contexts

    Peer-reviewed papers discuss LL-37 in specific lab settings. The points below reflect research questions, not health claims.

    Research vs. personal use: Literature describes experiments in cells and animals. That is distinct from real-world use. Our products are for laboratory research only.

    Typical study contexts

  • Innate immune activation or viral challenge models in animals.
  • Thymic peptides and host-defence research in controlled preclinical settings.
  • Forms amphipathic tetrameric transmembrane channels disrupting bacterial membrane integrity via electrostatic insertion.
  • Broad-spectrum antimicrobial activity against Gram-positive, Gram-negative bacteria, fungi, and enveloped viruses.
  • Inhibits bacterial biofilm formation through membrane disruption at sub-MIC concentrations.
  • Interacts with intracellular polyanionic targets (DNA, RNA, ribosomes) for secondary bactericidal mechanisms.
  • Why Immune / Anti-Inflammatory research matters

    Immune-focused peptides are studied for innate responses, viral models or antimicrobial biology in controlled experiments.

    Mechanisms (technical review)

    Our datasheet lists mechanistic themes from preclinical work. These are research endpoints, not health claims.

  • Forms amphipathic tetrameric transmembrane channels disrupting bacterial membrane integrity via electrostatic insertion
  • Broad-spectrum antimicrobial activity against Gram-positive, Gram-negative bacteria, fungi, and enveloped viruses
  • Inhibits bacterial biofilm formation through membrane disruption at sub-MIC concentrations
  • Interacts with intracellular polyanionic targets (DNA, RNA, ribosomes) for secondary bactericidal mechanisms
  • Activates FPRL-1, P2X7, and EGFR receptors modulating immune cell chemotaxis and wound healing
  • Promotes angiogenesis and keratinocyte migration for enhanced wound closure
  • Lab handling & preparation

  • Storage: Lyophilised powder: store in freezer (−20 °C). Reconstituted: refrigerate 1–6 °C, away from sunlight. Use within the validated stability window for the specific batch and formulation.. See the storage guide.
  • Research dosing context: Literature typically discusses 50-200 μg per day. Once daily subcutaneous injection or topical application MW ~4493 Da, 37 amino acids with net charge +6 from 16 charged residues. Adopts helix-break-helix conformation in membrane environments. Limitations include susceptibility to proteolytic degradation, dose-dependent cytotoxicity, and high production costs. Vitamin D supplementation upregulates endogenous LL-37 production in vivo.
  • Preparation: Follow the reconstitution guide. Confirm volumes with the calculator.
  • Purity check: Use the COA reading guide and the published LL-37 Certificate of Analysis.
  • Common Questions People Are Asking

    What is LL-37 and how does it work?

    LL-37 is the only human cathelicidin antimicrobial peptide - a 37-amino-acid, positively charged (net +6) amphipathic helix cleaved from the precursor hCAP-18. Its primary mechanism is physical: it binds the anionic surface of microbial membranes and disrupts them, while also neutralising bacterial endotoxin (LPS) and acting as an alarmin that signals the wider innate immune system. New-U supplies it for laboratory research only.

    What does the LL-37 research actually show?

    Preclinical and cell-based studies report broad-spectrum antimicrobial activity (Gram-positive and Gram-negative bacteria, fungi, enveloped viruses), inhibition of biofilm formation, and roles in wound healing and immune signalling; its dysregulation is also studied in inflammatory skin disease such as rosacea, psoriasis and atopic dermatitis (Reinholz & Ruzicka et al., 2012). These are research findings in models, not a promise of any effect in humans.

    Is LL-37 legal, and is it approved for use?

    LL-37 is not an FDA-approved drug; it is sold strictly as a research compound for laboratory use, not for human consumption. It has appeared in early-phase clinical research (for example topical wound-healing studies), but it remains investigational. Legal status varies by jurisdiction, so confirm your local rules before purchasing.

    Can bacteria develop resistance to LL-37?

    Resistance is much harder to evolve against membrane-targeting peptides than against receptor- or enzyme-targeting antibiotics, because there is no single protein for the pathogen to mutate. Some bacteria modify their outer-membrane charge to reduce electrostatic attraction, but full escape is rare - part of why antimicrobial peptides like LL-37 are such an active research area in the antibiotic-resistance era.

    What is the vitamin D connection?

    Cathelicidin (CAMP) gene expression is directly regulated by the vitamin D receptor. Calcitriol (the active form of vitamin D) upregulates endogenous LL-37 production, which is one of the mechanisms behind the observed relationship between vitamin D status and susceptibility to respiratory and tuberculosis infections.

    Why is LL-37 dose-dependent for cytotoxicity?

    Like most amphipathic antimicrobial peptides, LL-37 is selectively toxic to microbial membranes at low concentrations but loses selectivity at high concentrations, affecting host-cell membranes as well. Research protocols need to balance antimicrobial efficacy against host-cell tolerability, which is a general limitation of the class.

    How should LL-37 be stored?

    Keep the lyophilised powder frozen at −20 °C. After reconstitution with bacteriostatic water, refrigerate at 1-6 °C and protect from light. LL-37 is susceptible to proteolytic degradation, so use reconstituted material promptly and avoid repeated freeze-thaw cycles.

    Is this page medical advice? Can I use LL-37 for my health?

    No, and no. This article is educational only. We do not provide dosing, medical recommendations, or health claims. Our products are sold strictly for laboratory research, not for personal use of any kind.

    Where do I find LL-37 specs, purity certificates and pricing?

    Open the shop listing via “View product details.” There you will see batch specs, the Certificate of Analysis (COA), concentration, purity grade, and available SKUs with current pricing.

    Related peptide guides

    Other compounds researchers often read about alongside LL-37.

  • TB-500 - companion guide
  • BPC-157 - companion guide
  • GHK-Cu - companion guide
  • Melanotan-2 - companion guide
  • Scientific sources & further reading

    Primary literature and registries for LL-37, plus mainstream coverage of the peptide category. Research use only - not medical advice.

    Databases & literature:

  • PubMed: peer-reviewed literature on LL-37
  • ClinicalTrials.gov: registered studies on LL-37
  • LL-37: Wikipedia
  • Peptides in the news:

  • WebMD: consumer health reference
  • BBC News: Health
  • CNN Health: “Peptides: what to know about the wellness trend”
  • Sky News: “Can peptides make America healthy again?”
  • Sky News: “Inside the exploding US peptides craze” (video)
  • Sky News Australia: “Black market peptide trade explodes as influencers fuel uptick in use”
  • Sky News Australia: “Backyard peptide boom sparks alarm” (video)
  • Sky News Australia: “Oprah reveals struggle with shame of weight-loss drugs”
  • Ready to order? View full product specs

    Access concentration, batch info, variants, and current pricing on our shop.

    Also known as: LL-37, Cathelicidin, hCAP-18 Active Fragment, Human Cathelicidin Antimicrobial Peptide, CAMP, Cathelicidin LL-37, Antimicrobial Peptide LL-37

    PRECISION. PURITY. PERFORMANCE.

    Research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical & Freedom Diagnostics, with Certificates of Analysis published per released batch. Supplied strictly for laboratory research use.

    Shop

  • All research compounds
  • Price list
  • Where to buy peptides
  • Compare compounds
  • Compare vial sizes
  • Affiliate programme
  • Research

  • Peptide 101
  • Published COAs
  • Research areas
  • Research blog
  • How-to guides
  • Peptide guides
  • Research glossary
  • Support

  • Track your order
  • Contact us
  • Shipping & delivery
  • FAQ
  • Community forum
  • Customer reviews
  • Refund policy
  • Ways to Pay

  • Google Pay
  • Apple Pay
  • Venmo
  • PayPal
  • Cryptocurrency
  • Cash App
  • Card payments
  • Bank transfer (SEPA)
  • Paying with crypto
  • Live crypto prices
  • Shop by goal

  • Metabolic Signalling
  • GH-Axis Research
  • Muscle & IGF Research
  • Tissue and Cellular Models
  • Regenerative Research
  • Cellular Senescence Research
  • Cognitive Research
  • Multi-Compound Blends
  • Accessories
  • Shop by compound

  • BPC-157
  • TB-500
  • GHK-Cu
  • Tesamorelin
  • Semaglutide
  • CJC-1295 (without DAC)
  • Ipamorelin
  • MOTS-C
  • All compounds →
  • Shop by region

  • United Kingdom
  • Australia
  • Canada
  • Canada (FR)
  • Ireland
  • Malta
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Portugal
  • Greece
  • Austria
  • Poland
  • Sweden
  • Finland
  • Denmark
  • Norway
  • Croatia
  • Slovakia
  • Slovenia
  • Estonia
  • Latvia
  • Lithuania
  • Czechia
  • Hungary
  • Romania
  • Bulgaria
  • Belgium
  • Belgium (FR)
  • Luxembourg
  • United States
  • Northern Ireland
  • Research use only (RUO). All products are sold strictly for laboratory and research purposes — not for human or veterinary consumption. Purchasers must be 21 or older.

    All rights reserved. Copyright of New-U held with Hilxera Distribution Services LLC 2026.

    Website & business operated by Hilxera Distribution Services LLC. Registered in Wyoming, ID: 2026-001928701.

    © 2026 New-U Research Compounds · new-u.io

    Research use only — not for human consumption. All products are supplied strictly for laboratory research purposes.

    © 2026 New-U Research Compounds · new-u.io — Copyright held with Hilxera Distribution Services LLC. All rights reserved.